Leqembi Receives Positive Public Reimbursement Recommendation in Canada BioArctic announced that CDA-AMC has issued a final recommendation supporting public reimbursement of Leqembi (lecanemab) for el...
Takeaways: Felix’s sleep apnea program, built with MedSleep, creates a virtual front door for one of Canada’s most under‑diagnosed chronic conditions (≈1 in 4 adults at high risk, only ~3%...
Takeaways: Light AI’s Health Canada Class II license for QuickScan Strep A clears the way to commercialize an AI‑based clinical decision support tool that analyzes digital throat images to h...
Takeaways: Grey Matter’s focused ultrasound platform aims to offer a non‑invasive option for people whose depression hasn’t improved with medications or therapy, by precisely stimulating deep brain ci...
Takeaways: The approval should help Kardium gain early adoption in Canada by offering a single-catheter solution that combines high-density mapping and PFA with strong PULSAR data (78%...
Takeaways Dexcom G7 15 Day’s Health Canada authorization sets up a step-change in CGM economics and adoption once launched, by extending wear to 15.5 days and offering top-tier accuracy and dire...
For most of modern medicine, the pharmaceutical industry has operated largely within a reactive healthcare model, developing therapies designed to treat diseases after they emerge. Today, however, adv...
Artificial intelligence is rapidly becoming embedded across the pharmaceutical value chain, from drug discovery and clinical trial optimization to manufacturing and commercialization. As the technolog...
Takeaways: Heidi’s native Accuro EMR integration gives it instant scale across Canada’s largest clinician EMR (25,000+ users), making it more sticky and defensible while enab...
Takeaways: This acquisition turbocharges Hims & Hers’ Canada growth by giving it a ready-made weight-management business and local provider network, while it becomes the first Canadian...
